Treuner J, Suder J, Keim M, Kaatsch P, Niethammer D
Department of Haematology and Oncology, Paediatric Centre, Olga Hospital, Stuttgart, West Germany.
Acta Oncol. 1989;28(1):67-72. doi: 10.3109/02841868909111184.
The relation between the initial tumour regression produced by chemotherapy and the later event-free survival was studied in a prospective multicentre study on soft-tissue sarcomas in children. The event-free survival rate in patients with complete remission after seven weeks of chemotherapy was 95%; in patients with incomplete tumour reduction of greater than 2/3, 61%; and in patients with tumour reduction of less than 2/3 but greater than 1/3, 31%. Patients with partial remission at week 7, who achieved complete remission by week 16 after additional chemotherapy had an event-free survival rate of 64%. A multivariate analysis suggested that the response per unit of time was an important prognostic factor.